ArdorComm Media Group

NSE

Zee Entertainment Gains 7% as Board to Consider Fund Raising on July 16

Shares of Zee Entertainment Enterprises Limited (ZEEL) surged by 7% to Rs 157.20 per share on the National Stock Exchange (NSE) during Friday’s intra-day trade, driven by heavy volumes. This uptick followed the company’s announcement that its board will convene on July 16 to deliberate on a fund-raising plan. In an exchange filing, ZEEL stated, “A meeting of the board of directors of the company is scheduled to be held on Tuesday, July 16, 2024, inter alia, to consider and approve the raising of funds through the issuance of appropriate instruments along with the terms and conditions of the appropriate instruments, subject to such regulatory/statutory approvals as may be required.” Last month, the board had given its in-principle approval for raising up to Rs 2,000 crore through the issue of securities via various modes, including private placement, qualified institutions placement (QIP), preferential issue, or other methods. By 11:15 AM, ZEEL emerged as the top gainer among the Nifty Midcap 100 index, rising by 6.2% to Rs 156.30. In contrast, the Nifty 50 and Nifty Midcap 100 index saw gains of 0.89% and 0.38%, respectively. A combined 26.16 million shares were traded on the NSE and BSE. Despite this recent surge, ZEEL has underperformed the market in 2024, declining by 45%, compared to a nearly 13% rally in the Nifty 50. The stock hit a 52-week low of Rs 125.50 on June 4, 2024. In its Q4FY24 earnings update, ZEEL mentioned significant ongoing efforts to implement margin improvement interventions across its business. The company anticipates that these efforts will enhance performance, with major costs incurred in Q1FY25 for implementing these interventions. This is expected to impact margins temporarily, with gradual improvement anticipated from Q2FY25. The company aims for industry-leading EBITDA margins of 18-20% by FY26. Emkay Global Financial Services noted that ZEEL’s Q1FY25 performance might be affected by a shift in advertisement spends, projecting marginal growth of 2% year-on-year for Q1 ad revenues. Subscription revenues are expected to grow steadily due to price hikes, while other sales and services should benefit from movie releases and syndication deals. ZEEL’s profitability may be impacted by one-time interventions as it strives to reach its medium-term targets.

Zee Entertainment Gains 7% as Board to Consider Fund Raising on July 16 Read More »

Max Health Shares Dip 4% as NSE Refuses Fine Waiver for Flouting Board Norms

News on health

Max Healthcare Institute Ltd faced a setback in its stock value as shares dipped by 4.4% to Rs 782 per share in Thursday’s intraday trading. This decline followed the National Stock Exchange’s decision not to waive off a fine amounting to Rs 2,36,000 imposed on the hospital chain. The refusal by NSE to grant the waiver came after Max Healthcare’s request for leniency regarding a fine imposed last year in November. The fine was levied for non-compliance with the board composition requirements outlined under regulation 17(1) of the SEBI Regulations, 2015. Despite this setback, Max Healthcare is continuing its growth trajectory with a significant investment plan. The company is gearing up to invest Rs 2500 crore in developing hospitals in Lucknow, with a particular focus on expanding its footprint in Uttar Pradesh. Max Healthcare had earlier acquired the 550-bed Sahara Hospital in Lucknow for Rs 940 crore, a move aimed at solidifying its position as a key player in the private healthcare sector in the state. The investment plan includes doubling the group’s capacity by adding 4,200 beds over the next four to five years, representing an investment of over Rs 5,000 crore. This expansion initiative aligns with Max Healthcare’s vision to enhance its presence and service offerings in the region. The acquisition of Sahara Hospital, now renamed Max Super Specialty Hospital, marks the beginning of Max Healthcare’s strategic expansion plans. The hospital, situated in Gomti Nagar, Lucknow, boasts 285 operational beds and occupies a 27-acre land area. Despite the recent stock price dip, Max Healthcare remains a significant player in the healthcare sector, managing 17 hospitals with over 3,500 beds and employing more than 4,800 clinicians across various locations including the Delhi National Capital Region, Mohali, Bathinda, Dehradun, and Mumbai. At 11:48 AM, Max Healthcare was trading 3.40% lower at Rs 790.20 per share. The stock has shown resilience over the past month, gaining 8.12%, and has demonstrated strong growth, rallying 36.66% over the last six months. Currently, it trades at a price-to-earnings multiple of 138.88.  

Max Health Shares Dip 4% as NSE Refuses Fine Waiver for Flouting Board Norms Read More »